New stomach mapping device could personalize dyspepsia care

NCT ID NCT06854120

Recruiting now Knowledge-focused Sponsor: University of Auckland, New Zealand Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a non-invasive device called Gastric Alimetry that records stomach electrical activity in people with functional dyspepsia or gastroparesis. Researchers will compare recordings taken before and during medication to see if the device can predict which treatment works best. The goal is to move beyond trial-and-error prescribing and tailor therapy to each person's stomach function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Gastric Alimetry device
What this could lead to: If successful, this could help doctors choose the right medication for each patient based on their stomach's electrical activity, rather than just symptoms.
What could go wrong: This is an early-stage observational study, not a treatment trial. The device may not reliably predict medication response, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FUNCTIONAL DYSPEPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dyspepsia functional gastric disease gastroparesis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FUNCTIONAL DYSPEPSIA GASTROPARESIS

Contacts and locations

Locations

Te Whatu Ora Waitemata
RECRUITING

Auckland, Auckland, 0622, New Zealand
Temple University
NOT_YET_RECRUITING

Philadelphia, Pennsylvania, 19122, United States
Western Sydney University
RECRUITING

Sydney, New South Wales, 2560, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.